![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update
As hematopoietic cell transplantation (HCT) and cellular therapy expand to new indications and international access improves, the volume of HCT performed annually continues to rise. Parallel improvements in HC...
-
Article
The association of body composition and outcomes following autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphoma
Recently there has been a growing interest in evaluating body composition as a marker for prognosis in cancer patients. The association of body composition parameters and outcomes has not been deeply investiga...
-
Article
Open AccessProphylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment Period
Our institution has used trimethoprim-sulfamethoxazole (TMP-SMX) as the antibacterial agent of choice for infection prophylaxis during the pre-engraftment period in the allogeneic transplant (allo-HCT) populat...
-
Article
Open AccessLeukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation
Graft-versus-leukemia (GvL) reactions are responsible for the effectiveness of allogeneic hematopoietic cell transplantation as a treatment modality for myeloid neoplasia, whereby donor T- effector cells recog...
-
Article
Resource utilization in patients with large B-cell lymphoma receiving tisagenlecleucel and axicabtagene ciloleucel
-
Article
Pattern of somatic mutation changes after allogeneic hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes
-
Article
Evaluation of pre-transplant risk assessments in allogeneic hematopoietic cell transplant
-
Article
Community health status and long-term outcomes in 1-year survivors of autologous and allogeneic hematopoietic cell transplantation
-
Chapter
Introduction
Cancer is a growing healthcare problem worldwide with significant public health and economic burden to both developed and develo** countries. According to the World Health Organization, cancer is the second ...
-
Article
Day 100 risk assessment tool predicts overall survival in allogeneic hematopoietic cell transplantation
-
Chapter
Psychosocial and Patient Support Services in Comprehensive Cancer Centers
Patient support and psychosocial services are an important aspect of cancer care. Comprehensive cancer centers need to provide a spectrum of these services to provide high-quality and holistic care to cancer p...
-
Chapter
Transplantation and Cellular Therapy
Comprehensive cancer services include provision of care to patients with advanced hematologic malignancies, among whom some patients are candidates for hematopoietic cell transplantation (HCT). HCT is a comple...
-
Article
The Democratization of Scientific Conferences: Twitter in the Era of COVID-19 and Beyond
The coronavirus disease 2019 (COVID-19) pandemic has had profound impacts upon scientific discourse in our field, most prominently through the abrupt transition of malignant hematology conferences to all-digit...
-
Reference Work Entry In depth
Allogeneic Transplant Overview and Matched Related Donor Transplant
Allogeneic hematopoietic cell transplantation utilizes the potential of an alloreactive graft-versus-tumor effect for the treatment of hematologic malignancies and other malignant and nonmalignant diseases. Si...
-
Article
To D or not to D: vitamin D in hematopoietic cell transplantation
Vitamin D plays an essential role in bone health, immune tolerance, and immune modulation. Autologous and allogeneic hematopoietic cell transplantation (HCT) recipients are at increased risk of vitamin D defic...
-
Article
Age and gender differences in financial distress among hematopoietic cell transplant survivors
Cancer has long-term financial consequences. Adolescent and young adult (AYA) and middle-aged cancer survivors may experience more financial toxicity than older adults. This study examined age differences in f...
-
Article
Patient-reported outcomes in acute graft-versus-host disease: optimizing patient care and clinical trial endpoints
Patient-reported outcomes (PROs) refer to patient perceived and reported health-related quality of life (HRQOL), functional status, and symptom burden. PROs have become an important measure in oncologic care t...
-
Article
Engaging hematopoietic cell transplantation patients and caregivers in the design of print and mobile application individualized survivorship care plan tools
INSPIRE (INteractive Survivorship Program with Information and REsources) is an online health program that includes a mobile app, website, health action plan, and individualized survivorship care plans for adu...
-
Article
Healthcare Costs of Treating Privately Insured Patients with Acute Myeloid Leukemia in the United States from 2004 to 2014: A Generalized Additive Modeling Approach
The primary objective of this study was to predict healthcare cost trajectories for patients with newly diagnosed acute myeloid leukemia (AML) receiving allogeneic hematopoietic cell transplantation (alloHCT),...
-
Article
Transplant center characteristics and survival after allogeneic hematopoietic cell transplantation in adults
Allogeneic hematopoietic cell transplantation (alloHCT) is a highly specialized procedure. We surveyed adult transplant centers in the United States (US) and then used data reported to the Center for Internati...